Palantir's NHS data deal called in for a second opinion

Experts have welcomed the UK government's decision to review its contract with Palantir to provide software central to tackling the elective care backlog. The US spy-tech biz has, for some, been a controversial presence at the heart of the National Health Service in England since it was awarded a contract for just £1 to help provide data tools during the pandemic. It later won £60 million in uncontested deals.